Immunosuppressives, Retinoids and New Trends in Psoriasis Therapy
Authors:
M. Svozil
Authors‘ workplace:
Katedra farmaceutické technologie Farmaceutické fakulty Univerzity Karlovy, Hradec Králové
Published in:
Čes. slov. Farm., 2002; , 267-272
Category:
Overview
Some psoriasis forms can be successfully treated with topical medicaments; serious and extensiveforms cannot be cured without systemic treatment with retinoids (etretinate, acitretin, tazarotene)or withimmunosuppressives (methotrexate, cyclosporine A, tacrolimus,SDZ 281-240). Immuno-therapyand nucleotide analogues are being newly introduced, a number of potentially effectivesubstances interfering with pathogenetic mechanisms participating in the emergence and self-prolongationof psoriasis are in the stage of research and clinical trials, and gene therapy possibilitiesare being investigated.The development and testing of drugs serving therapy for psoriasis correlateswith the development of knowledge about the origins of the disease and the mechanisms of howantipsoriatics in current use as well as the new potential ones work.
Key words:
psoriasis – therapy – drugs – immunosuppressives – retinoids
Labels
Pharmacy Clinical pharmacologyArticle was published in
Czech and Slovak Pharmacy
2002 Issue 6
Most read in this issue
- The Scullcap Plant (Scutellaria baicalensis Georgi) – A Potential Resource of New Drugs
- Therapy of Hyperhomocysteinemia by Vitamin B12
- Immunosuppressives, Retinoids and New Trends in Psoriasis Therapy
- Knowledge of Patients about the OTC Preparation as the Result of Pharmacist – PatientConsultations